Free Trial

Stephens Has Lowered Expectations for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare logo with Medical background

Addus HomeCare (NASDAQ:ADUS - Get Free Report) had its price objective decreased by equities research analysts at Stephens from $153.00 to $142.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an "overweight" rating on the stock. Stephens' target price indicates a potential upside of 48.27% from the stock's current price.

Other research analysts also recently issued reports about the company. Royal Bank of Canada restated an "outperform" rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. JMP Securities started coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They issued an "outperform" rating and a $150.00 price target for the company. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. StockNews.com raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Friday, January 24th. Finally, Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $132.78.

Get Our Latest Report on Addus HomeCare

Addus HomeCare Trading Down 1.0 %

Shares of Addus HomeCare stock traded down $0.98 during trading on Wednesday, reaching $95.77. The stock had a trading volume of 247,318 shares, compared to its average volume of 143,127. The company has a market capitalization of $1.74 billion, a price-to-earnings ratio of 21.92, a P/E/G ratio of 1.41 and a beta of 1.00. The stock has a fifty day moving average price of $122.60 and a two-hundred day moving average price of $126.08. Addus HomeCare has a 52 week low of $87.88 and a 52 week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, equities analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of the business's stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares of the company's stock, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now directly owns 79,397 shares of the company's stock, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.60% of the company's stock.

Institutional Trading of Addus HomeCare

Large investors have recently made changes to their positions in the company. Creative Planning raised its holdings in shares of Addus HomeCare by 5.8% during the 3rd quarter. Creative Planning now owns 4,910 shares of the company's stock worth $653,000 after buying an additional 267 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in shares of Addus HomeCare by 7.4% during the 3rd quarter. Louisiana State Employees Retirement System now owns 8,700 shares of the company's stock worth $1,157,000 after buying an additional 600 shares in the last quarter. State of Alaska Department of Revenue raised its holdings in shares of Addus HomeCare by 7.6% during the 3rd quarter. State of Alaska Department of Revenue now owns 10,215 shares of the company's stock worth $1,358,000 after buying an additional 721 shares in the last quarter. J.W. Cole Advisors Inc. acquired a new stake in shares of Addus HomeCare in the 3rd quarter valued at approximately $251,000. Finally, Integrated Advisors Network LLC acquired a new stake in shares of Addus HomeCare in the 3rd quarter valued at approximately $523,000. Institutional investors and hedge funds own 95.35% of the company's stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

3 AI Stocks to Watch After NVIDIA’s Dip

3 AI Stocks to Watch After NVIDIA’s Dip

NVIDIA may be down, but the AI boom isn’t slowing anytime soon! While investors react to short-term price swings, smart money is looking at three stocks that could benefit from NVIDIA’s continued domi

Related Videos

5 Stocks to BUY NOW in March 2025
NVIDIA Revenue SOARS 78%, But Volatility Won’t STOP!
NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines